Scarica l'app Stockscreener
34.64
0.46%
-0.16
Dopo l'orario di chiusura:
34.64
Precedente Chiudi:
$34.80
Aprire:
$34.88
Volume 24 ore:
553.38K
Relative Volume:
0.54
Capitalizzazione di mercato:
$5.44B
Reddito:
$5.29B
Utile/perdita netta:
$191.46M
Rapporto P/E:
29.39
EPS:
1.1785
Flusso di cassa netto:
$298.82M
1 W Prestazione:
+2.82%
1M Prestazione:
-10.33%
6M Prestazione:
+189.39%
1 anno Prestazione:
+186.75%
Intervallo 1D:
$33.67
$35.34
Intervallo di 1 settimana:
$33.64
$36.55
Portata 52W:
$7.50
$43.08
Pacs Group Inc Stock (PACS) Company Profile
Nome
Pacs Group Inc
Settore
Industria
Telefono
(801) 447-9829
Indirizzo
90 S. 400 W. SUITE 700, SALT LAKE CITY
Compare PACS vs HCA, THC, FMS, ENSG, UHS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PACS
Pacs Group Inc
|
34.64 | 5.47B | 5.29B | 191.46M | 298.82M | 1.1785 |
|
HCA
Hca Healthcare Inc
|
499.68 | 112.27B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
205.11 | 17.67B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.11 | 12.52B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
202.49 | 11.91B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
187.22 | 11.58B | 17.36B | 1.51B | 849.25M | 23.15 |
Pacs Group Inc Stock (PACS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-06 | Ripresa | JP Morgan | Overweight |
| 2024-10-09 | Iniziato | UBS | Buy |
| 2024-09-11 | Ripresa | Citigroup | Buy |
| 2024-06-28 | Iniziato | Macquarie | Outperform |
| 2024-05-06 | Iniziato | Citigroup | Buy |
| 2024-05-06 | Iniziato | JP Morgan | Overweight |
| 2024-05-06 | Iniziato | Oppenheimer | Outperform |
| 2024-05-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-05-06 | Iniziato | Stephens | Overweight |
| 2024-05-06 | Iniziato | Truist | Buy |
Mostra tutto
Pacs Group Inc Borsa (PACS) Ultime notizie
PACS Group stockholders endorse directors, auditor and pay - MSN
Momentum Shift: Can PACS Group Inc reach resistance levels soon2026 Earnings Surprises & Daily Profit Maximizing Tips - baoquankhu1.vn
PACS Group to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 17, 2026 - geneonline.com
Jergensen Joshua, president & COO of PACS Group, sells $1.24 million in stock - Investing.com
PACS: Record 2025 growth, strong financials, and robust M&A pipeline position the company for 2026 - TradingView
Zacks Industry Outlook Highlights BrightSpring Health Services, InnovAge and PACS - The Globe and Mail
PACS Group, Inc. (PACS) Stock Price, News, Quote & History - Yahoo! Finance Canada
PACS Group, Inc. to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 17, 2026 - The Joplin Globe
3 Medical Service Industry Stocks Set to Counter Workforce Issues - TradingView
PACS Group (PACS) price target increased by 17.62% to 36.89 - MSN
PACS Group adds former CMS official Patrick Conway to board By Investing.com - Investing.com Nigeria
A Look At PACS Group (PACS) Valuation After Record Earnings And Zacks Rank Upgrade - simplywall.st
Live PACS Group, Inc. (PACS) Technical Analysis - Traders Union
Technical Reactions to PACS Trends in Macro Strategies - Stock Traders Daily
PACS Group (PACS) Insider Trading Activity 2026 $PACS - MarketBeat
Does PACS Group’s (PACS) Optum CEO Board Addition Reframe Its Value-Based Care Ambitions? - Sahm
PACS Group Earnings Call Highlights Profitable, Disciplined Growth - The Globe and Mail
PACS vs. MEDP: Which stock is the better value option? - MSN
PACS Group, Inc. (PACS) Raised to Strong Buy: The Reasons Explained - Bitget
PACS Group, Inc. (PACS) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Does PACS Group, Inc. (PACS) have the potential to rally 25.45% as Wall Street analysts expect? - MSN
Is PACS Group (PACS) Pricing Reflect Its Recent Share Price Pullback And Growth Hopes - Yahoo Finance
Mark Hancock - Forbes
[144] PACS Group, Inc. SEC Filing - Stock Titan
PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
PACS Group (PACS) executive Mark Hancock gifts 300,000 shares to charity - Stock Titan
2026-03-08 | PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:PACS | Press Release - Stockhouse
Pacs (PACS) Hits 52-Week High on Q3 Blowout - MSN
PACS Group (NYSE:PACS) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeat
PACS Group, Inc. 8-K Filing: Company Information, Common Stock Trading Details, and SEC Compliance Disclosure (March 2026) - Minichart
PACS Group adds former CMS official Patrick Conway to board - Investing.com
PACS Group Appoints Patrick Conway to Board of Directors - TipRanks
Director at PACS Group (PACS) receives 3,497 restricted stock units grant - Stock Titan
Patrick Hugh Conway joins PACS Group (PACS) insider roster with Form 3 - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages PACS Group, Inc. (PACS) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
PACS vs. MEDP: Which Stock Is the Better Value Option? - Bitget
PACS Group, Inc. Appoints Dr. Patrick Conway, MD, MSc to Board of Directors - 01net
Does PACS Group, Inc. (PACS) Have the Potential to Rally 25.45% as Wall Street Analysts Expect? - Finviz
PACS Group Appoints Dr. Patrick Conway to Board - National Today
Pacs Group, Inc. appoints Dr. Patrick Conway, MD, MSc to board of directors - marketscreener.com
Best Momentum Stock to Buy for March 5th - Yahoo Finance Australia
Best Value Stock to Buy for March 5th - Yahoo Finance
A Look At PACS Group (PACS) Valuation After Record 2025 Results And New 2026 Guidance - simplywall.st
5 Analysts Assess PACS Group: What You Need To Know - Benzinga
PACS Stock Receives Updated "Buy" Rating from UBS Today | PACS S - GuruFocus
PACS Group (NYSE:PACS) Price Target Raised to $44.00 at UBS Group - MarketBeat
UBS Adjusts PACS Group Price Target to $44 From $42, Maintains Buy Rating - marketscreener.com
PACS Group Inc (PACS) Shares Up 2.9% on Mar 4 - GuruFocus
Oppenheimer Adjusts Price Target on PACS Group to $42 From $40, Maintains Outperform Rating - marketscreener.com
PACS Group (NYSE:PACS) Price Target Raised to $42.00 at Oppenheimer - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, Inc. (PACS) And Encourages Shareholders to Connect - ACCESS Newswire
Pacs Group Inc Azioni (PACS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.42%
1.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):